Cited by 786Viral Infectious Diseases and Gene Expression in InsectsFungal and yeast genetics researchMonoclonal and Polyclonal Antibodies Research

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line

Open access

Abstract

Since 1987, immortalized cells from the ovary of a Chinese hamster have been the workhorse for producing recombinant therapeutics, including monoclonal antibodies, blood factors, hormones, growth factors and enzymes. Xu et al. provide the genome sequence of the ancestral CHO-K1 cell line, which should aid in the optimization of current production cell lines. Chinese hamster ovary (CHO)–derived cell lines are the preferred host cells for the production of therapeutic proteins. Here we present a draft genomic sequence of the CHO-K1 ancestral cell line. The assembly comprises 2.45 Gb of genomic sequence, with 24,383 predicted genes. We associate most of the assembled scaffolds with 21 chromosomes isolated by microfluidics to identify chromosomal locations of genes. Furthermore, we investigate genes involved in glycosylation, which affect therapeutic protein quality, and viral susceptibility genes, which are relevant to cell engineering and regulatory concerns. Homologs of most human glycosylation-associated genes are present in the CHO-K1 genome, although 141 of these homologs are not expressed under exponential growth conditions. Many important viral entry genes are also present in the genome but not expressed, which may explain the unusual viral resistance property of CHO cell lines. We discuss how the availability of this genome sequence may facilitate genome-scale science for the optimization of biopharmaceutical protein production.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nbt.1932

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 53 references

1 of the 53 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 401–500 of 786

Metadata

Authors
Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., Andersen, M. R., Neff, N., Passarelli, B., Koh, W., Fan, H. C., Wang, J., Gui, Y., Lee, K. H., Betenbaugh, M. J., Quake, S. R., Famili, I., Palsson, B. O., & Wang, J.
Affiliations
  • BGI Group (China) (CN)
  • Peking University Shenzhen Hospital (CN)
  • Delaware Biotechnology Institute (US)
  • Technical University of Denmark (DK)
  • Howard Hughes Medical Institute (US)
  • Johns Hopkins University (US)
Corresponding author
  • Wang, Jianbin
  • Wang, Jun
Venue
Nature Biotechnology
Published
2011-08
Volume
29
Issue
8
Pages
735-741
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W2093343938
Cited by
785
References
53
Citations by year
2026: 22 · 2025: 25 · 2024: 37 · 2023: 35 · 2022: 39 · 2021: 58 · 2020: 38 · 2019: 45 · 2018: 78 · 2017: 57 · 2016: 59 · 2015: 77 · 2014: 79 · 2013: 64 · 2012: 53
FWCI
27.29
Type
journal article
Language
en
Open access
Locations
  • Nature Biotechnology (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
Funders
  • Novo Nordisk Fonden (NNF10CC1016517)
  • National Cancer Institute (R44CA139977)
  • National Center for Research Resources (P20RR016472)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
Keywords
CHO-K1 cells, CHO cells, draft genome sequence, therapeutic protein production, monoclonal antibodies, virus resistance, cell line engineering, genome assembly, gene expression
MeSH terms
Animals, Chromosome Mapping, Cricetulus, Glycosylation, Cricetinae, Models, Biological, Molecular Sequence Data, CHO Cells, Genome, Sequence Analysis, DNA, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review